Drug Profile
Research programme: casein kinase II inhibitors - Cylene
Alternative Names: CK-5011; CK2 inhibitors; CX-5011Latest Information Update: 24 Dec 2013
Price :
$50
*
At a glance
- Originator Cylene Pharmaceuticals
- Class Antineoplastics; Small molecules
- Mechanism of Action Casein kinase II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer